These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30252758)

  • 1. What are the new vaccination recommendations for herpes zoster?
    Mospan CM; Colvin N
    JAAPA; 2018 Oct; 31(10):14-15. PubMed ID: 30252758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
    Brotherton AL; Shah R
    R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination to prevent herpes zoster and postherpetic neuralgia.
    Oxman MN
    Hum Vaccin; 2007; 3(2):64-8. PubMed ID: 17299270
    [No Abstract]   [Full Text] [Related]  

  • 4. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
    Prosser LA; Harpaz R; Rose AM; Gebremariam A; Guo A; Ortega-Sanchez IR; Zhou F; Dooling K
    Ann Intern Med; 2019 Mar; 170(6):380-388. PubMed ID: 30776797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.
    Amirthalingam G; Andrews N; Keel P; Mullett D; Correa A; de Lusignan S; Ramsay M
    Lancet Public Health; 2018 Feb; 3(2):e82-e90. PubMed ID: 29276017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Rothberg MB; Virapongse A; Smith KJ
    Clin Infect Dis; 2007 May; 44(10):1280-8. PubMed ID: 17443464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.
    Keating GM
    Drugs; 2013 Jul; 73(11):1227-44. PubMed ID: 23839657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR; Farrokh P; Gandhi MA; Slish JC
    Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].
    Gil de Miguel A
    An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against the shingles].
    Olsen DB
    Tidsskr Nor Laegeforen; 2015 May; 135(9):834. PubMed ID: 25991620
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.
    Closmann JJ; Fielding CG; Pogrel MA
    Gen Dent; 2008; 56(6):563-6; quiz 567-8, 591-2. PubMed ID: 18810918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
    Le P; Rothberg MB
    Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shingles Vaccination.
    Jin J
    JAMA; 2018 Jul; 320(4):416. PubMed ID: 30043067
    [No Abstract]   [Full Text] [Related]  

  • 20. Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
    Keating GM
    BioDrugs; 2016 Jun; 30(3):243-54. PubMed ID: 27189459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.